|1.||Pawlak, Krystyna: 7 articles (09/2010 - 01/2004)|
|2.||Pawlak, Dariusz: 7 articles (09/2010 - 01/2004)|
|3.||Mysliwiec, Michal: 6 articles (09/2010 - 01/2004)|
|4.||Douglas, Steven D: 6 articles (05/2004 - 11/2002)|
|5.||Guo, Chang-Jiang: 6 articles (05/2004 - 11/2002)|
|6.||Ho, Wen-Zhe: 6 articles (05/2004 - 11/2002)|
|7.||Bursill, Christina A: 4 articles (07/2009 - 10/2004)|
|8.||Lehner, T: 4 articles (08/2004 - 04/2000)|
|9.||Wang, Y: 4 articles (08/2004 - 04/2000)|
|10.||Song, Li: 4 articles (05/2004 - 05/2003)|
02/01/2005 - "High production of beta-chemokines and CD8+ T cell anti-viral factors in naive as well as in vaccinated macaques has been associated with complete or partial protection against SIV infection indicating that genetic or environmental factors may influence their production. "
07/01/1999 - "It has been controversial whether CD34+ stem cells are susceptible to HIV-1 infection and whether high levels of beta-chemokines are beneficial for suppressing HIV-1 infection during DC maturation. "
07/01/2002 - "Our observations support our previous findings that the genetic background of the host and/or environmental factors are involved in the chemokine production and that beta-chemokines contribute to protection against HIV/SIV infection."
08/01/2000 - "The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection."
03/31/1998 - "C-C chemokines, pivotal in protection against HIV type 1 infection."
|2.||Acquired Immunodeficiency Syndrome (AIDS)
01/01/1998 - "As a consequence, early release of beta-chemokines could enhance host resistance towards HIV-1, and, in infected people, inhibit viral replication and evolution towards AIDS."
11/01/1997 - "In children who progressed to AIDS without a shift to CXCR4 usage, all the sequential isolates were CCR5-dependent but showed a reduced sensitivity to C-C chemokines. "
08/15/1997 - "50% of the AIDS patients, however, had NSI viruses that were sensitive to beta-chemokines. "
08/15/1997 - "Maximal production of these beta-chemokines by activated peripheral blood cells was higher in the infected individuals than in uninfected individuals, but no significant difference was observed between healthy infected subjects and AIDS patients. "
01/01/2000 - "Patients with slow disease progression produced higher levels of beta-chemokines than those detected in children with AIDS. "
10/15/2006 - "m35K may be a useful tool to study the role of CC chemokines in leukocyte trafficking and block the recruitment of monocytes in chronic inflammation."
05/01/1995 - "Recent studies have shown that CC chemokines act on monocytes, lymphocytes, eosinophils and basophils, but not neutrophils, with distinct target cell selectivities, possibly explaining the selective attraction and activation of these cell types in different types of chronic inflammation and allergic disease. "
12/01/2013 - "We conclude that Pglyrp1 expressed by hematopoietic cells, such as alveolar macrophages, mediates HDM-induced airway inflammation by up-regulating the production of C-C chemokines that recruit eosinophils and Th2 cells to the lung. "
01/01/2010 - "Furthermore, PS nanoparticles can evoke skin inflammation via the overexpression of CC-chemokines even in the absence of allergen in atopic subjects."
10/01/2009 - "It negatively regulates inflammation by targeting CC chemokines to cellular internalization and degradation. "
|4.||Interstitial Lung Diseases (Interstitial Lung Disease)
07/01/2011 - "Few studies have evaluated the efficacy of therapeutically targeting CC chemokines and their receptors during interstitial lung diseases. "
01/01/2009 - "CC chemokines play important roles in the pathogenesis of interstitial lung diseases. "
04/01/2005 - "CC chemokines play an important role in the pathogenetic mechanisms of interstitial lung disease, while a downregulation of CC chemokine receptor (CCR)5 in the fibrotic stages of sarcoidosis has been observed. "
12/01/2003 - "The role of the beta chemokines in experimental obliterative bronchiolitis."
12/01/2003 - "This study determined if antibody antagonization of beta chemokines conferred protection against the development of experimental obliterative bronchiolitis (OB) in a heterotopic rat tracheal allograft model. "
02/01/2005 - "In subjects with influenza virus infection, concentrations of the beta chemokine macrophage inflammatory protein-1alpha (MIP-1alpha), but not other beta chemokines, in nasopharyngeal secretions (NPS) were greater among infants with more severe, hypoxic bronchiolitis than in subjects with mild, nonhypoxic bronchiolitis, or upper respiratory tract infection alone. "
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|6.||Interferon-gamma (Interferon, gamma)
|8.||Macrophage Inflammatory Proteins
|9.||Interleukin-4 (Interleukin 4)
|1.||Homologous Transplantation (Allograft)
|4.||Highly Active Antiretroviral Therapy (HAART)